CEFTRIAXONE 250mg. IP + SULBACTAM 125mg. IP

An antibacterial agent that fights against a variety of serious infections. (M C Nahata, 1985) An effective and well-tolerated drug for the treatment of intermediate and severe bacterial infections caused by resistant strains. (Xiaojuan Xin, 2013) Has better bactericidal properties and reduces the probability of resistance development. (S.M. Shrivastava, 2009) A highly effective in treating gonococcal infections. (K Panikabutra C. A., 1985) An important third-generation cephalosporin in the treatment of serious community-acquired and nosocomial infections. (Harriet M Lamb, 2002) An effective regimen in the treatment of uncomplicated gonococcal infections of the pharynx, anorectum, cervix, and urethra. (Judson, 1986) More active than penicillin G against both beta-lactamase-positive and -negative strains of Neisseria gonorrhoeae. (Judson, 1986) Possesses a broad spectrum of antimicrobial activity against gram-positive and gram-negative aerobes commonly associated with serious infections. (R Davis, 1994) Offers an alternative for the treatment of serious infections due to multidrug-resistant Gram-negative bacteria. (D M Richards, 1984) More cost-effective than ceftazidime, penicillins, and cephalosporins for the treatment of community-acquired pneumonia. (R Davis, 1994) A beneficial agent for the treatment of serious gram-negative infections in seriously ill patients. (B E Scully, 1984)